Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells
Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP...
Saved in:
Published in | Nature communications Vol. 14; no. 1; pp. 8102 - 17 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
07.12.2023
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
ISSN | 2041-1723 2041-1723 |
DOI | 10.1038/s41467-023-43697-y |
Cover
Abstract | Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of
Tet2
. DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by
Tet2
-deficient HSPCs, and thus IL1β enhances the self-renewing ability of
Tet2
-deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that
Tet2
is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis.
The expansion of cells with TET2 mutations within the blood is associated with increased risk for all-cause mortality, development of leukemia and cardiovascular disease. Here authors show IL1 promotes the clonal expansion TET2 knockout cells, enhancing their self-renewal, promoting their myeloid bias and impairing an IL1 driven loss of methylation at lymphoid and erythroid regulatory elements. |
---|---|
AbstractList | Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of Tet2. DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by Tet2-deficient HSPCs, and thus IL1β enhances the self-renewing ability of Tet2-deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that Tet2 is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis.Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of Tet2. DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by Tet2-deficient HSPCs, and thus IL1β enhances the self-renewing ability of Tet2-deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that Tet2 is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis. Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of Tet2 . DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by Tet2 -deficient HSPCs, and thus IL1β enhances the self-renewing ability of Tet2 -deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that Tet2 is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis. Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of Tet2 . DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by Tet2 -deficient HSPCs, and thus IL1β enhances the self-renewing ability of Tet2 -deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that Tet2 is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis. The expansion of cells with TET2 mutations within the blood is associated with increased risk for all-cause mortality, development of leukemia and cardiovascular disease. Here authors show IL1 promotes the clonal expansion TET2 knockout cells, enhancing their self-renewal, promoting their myeloid bias and impairing an IL1 driven loss of methylation at lymphoid and erythroid regulatory elements. Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of Tet2. DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by Tet2-deficient HSPCs, and thus IL1β enhances the self-renewing ability of Tet2-deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that Tet2 is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis. Abstract Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of Tet2. DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by Tet2-deficient HSPCs, and thus IL1β enhances the self-renewing ability of Tet2-deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that Tet2 is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis. Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When linked to somatic mutations in myeloid malignancy-associated genes, such as TET2-mediated clonal hematopoiesis of indeterminate potential or CHIP, it represents increased risk for hematological malignancies and cardiovascular disease. IL1β is elevated in patients with CHIP, however, its effect is not well understood. Here we show that IL1β promotes expansion of pro-inflammatory monocytes/macrophages, coinciding with a failure in the demethylation of lymphoid and erythroid lineage associated enhancers and transcription factor binding sites, in a mouse model of CHIP with hematopoietic-cell-specific deletion of Tet2. DNA-methylation is significantly lost in wild type HSPCs upon IL1β administration, which is resisted by Tet2-deficient HSPCs, and thus IL1β enhances the self-renewing ability of Tet2-deficient HSPCs by upregulating genes associated with self-renewal and by resisting demethylation of transcription factor binding sites related to terminal differentiation. Using aged mouse models and human progenitors, we demonstrate that targeting IL1 signaling could represent an early intervention strategy in preleukemic disorders. In summary, our results show that Tet2 is an important mediator of an IL1β-promoted epigenetic program to maintain the fine balance between self-renewal and lineage differentiation during hematopoiesis.The expansion of cells with TET2 mutations within the blood is associated with increased risk for all-cause mortality, development of leukemia and cardiovascular disease. Here authors show IL1 promotes the clonal expansion TET2 knockout cells, enhancing their self-renewal, promoting their myeloid bias and impairing an IL1 driven loss of methylation at lymphoid and erythroid regulatory elements. |
ArticleNumber | 8102 |
Author | Wu, G. Davis, B. A. Mohammed, H. Wolfe, E. Fleming, W. H. Cimmino, L. Mohammadhosseini, M. Conley, P. Agarwal, A. Goldman, D. Lin, H. Y. Strogantsev, R. Eden, C. McClatchy, J. |
Author_xml | – sequence: 1 givenname: J. surname: McClatchy fullname: McClatchy, J. organization: Division of Oncological Sciences, Oregon Health & Science University, Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University – sequence: 2 givenname: R. surname: Strogantsev fullname: Strogantsev, R. organization: Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University – sequence: 3 givenname: E. orcidid: 0000-0003-1808-7012 surname: Wolfe fullname: Wolfe, E. organization: Division of Oncological Sciences, Oregon Health & Science University, Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University – sequence: 4 givenname: H. Y. surname: Lin fullname: Lin, H. Y. organization: Division of Oncological Sciences, Oregon Health & Science University, Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University – sequence: 5 givenname: M. surname: Mohammadhosseini fullname: Mohammadhosseini, M. organization: Division of Oncological Sciences, Oregon Health & Science University, Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University – sequence: 6 givenname: B. A. orcidid: 0000-0001-7985-1921 surname: Davis fullname: Davis, B. A. organization: Division of Oncological Sciences, Oregon Health & Science University, Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University – sequence: 7 givenname: C. surname: Eden fullname: Eden, C. organization: Division of Oncological Sciences, Oregon Health & Science University, Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University – sequence: 8 givenname: D. surname: Goldman fullname: Goldman, D. organization: Division of Hematology & Medical Oncology, Oregon Health & Science University, Division of Pediatric Hematology and Oncology, Oregon Health & Science University – sequence: 9 givenname: W. H. surname: Fleming fullname: Fleming, W. H. organization: Division of Hematology & Medical Oncology, Oregon Health & Science University, Division of Pediatric Hematology and Oncology, Oregon Health & Science University – sequence: 10 givenname: P. surname: Conley fullname: Conley, P. organization: Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University – sequence: 11 givenname: G. surname: Wu fullname: Wu, G. organization: Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University – sequence: 12 givenname: L. orcidid: 0000-0002-4218-582X surname: Cimmino fullname: Cimmino, L. organization: University of Miami, Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center – sequence: 13 givenname: H. surname: Mohammed fullname: Mohammed, H. organization: Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University – sequence: 14 givenname: A. orcidid: 0000-0002-8319-6162 surname: Agarwal fullname: Agarwal, A. email: agarwala@ohsu.edu organization: Division of Oncological Sciences, Oregon Health & Science University, Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Division of Hematology & Medical Oncology, Oregon Health & Science University, Department of Molecular and Medical Genetics, Oregon Health & Science University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38062031$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc2O0zAURiM0iBnKvAALFIkNm4D_YjtLVA1QqRKb7i3HvimuEjvYiVAfgpfhQXgmnLYMo1mMyMZRfL5PN_e8LK588FAUrzF6jxGVHxLDjIsKEVoxyhtRHZ8VNwQxXGFB6NWD9-viNqUDyg9tsGTsRXFNJeIEUXxT_Fz3weu-_AaDnsIYHCSXygi9nsCWu7sdKfuQUhW6qpu9mVzwpRtGsJDKzRb__lUNYN0JhtHtwcPkTM6PMeyjHgbn96XzD-qX6zTBUGpvy4UC76YQSwN9n14VzzvdJ7i9nKti9-lut_5Sbb9-3qw_bivDZD1VLbLADepqYXHLGK4JrgEaw6zsJGpITSVrMacCODMWS0MEWG4bwm3bGkJXxeZca4M-qDG6QcejCtqp04cQ90rHPGgPinEkqOE1dNAxQXFjrOgAWEOsNbSluYueu2Y_6uMP3ff3hRipRZU6q1JZlTqpUsecendO5Q18nyFNanBpWYH2EOakSINIw2ohZEbfPkIPYY7ZWaZkk43yReWqeHOh5jYbuZ_hr-kMyDNgYvYZoVPGTXrxOUXt-qeHJY-i__WHl72kDPs9xH9jP5H6A4Ax4OA |
CitedBy_id | crossref_primary_10_1007_s00018_024_05261_9 crossref_primary_10_1016_j_exphem_2025_104727 crossref_primary_10_1186_s12933_025_02588_w crossref_primary_10_1182_blood_2023023105 crossref_primary_10_1007_s00277_025_06244_x crossref_primary_10_1172_JCI180066 crossref_primary_10_3389_fncel_2024_1487867 crossref_primary_10_26508_lsa_202402971 crossref_primary_10_1053_j_seminhematol_2024_09_005 crossref_primary_10_1182_bloodadvances_2024014698 crossref_primary_10_1172_JCI180068 crossref_primary_10_1186_s13148_024_01771_2 crossref_primary_10_1038_s41586_024_08163_9 crossref_primary_10_3390_cancers16152634 crossref_primary_10_1038_s41467_024_54290_2 crossref_primary_10_3390_ijms26020671 crossref_primary_10_1016_j_exphem_2024_104698 |
Cites_doi | 10.1172/jci.insight.135204 10.1038/s41586-018-0125-z 10.1016/j.jacc.2017.12.037 10.1016/j.stemcr.2020.02.011 10.1038/s41467-021-26093-2 10.1016/j.celrep.2017.10.112 10.1016/j.exphem.2017.08.001 10.1016/S0140-6736(17)32247-X 10.1038/s41375-019-0462-4 10.1016/j.it.2007.01.006 10.1371/journal.pone.0087646 10.1038/s41586-019-0969-x 10.1038/s41375-022-01665-3 10.1038/nprot.2016.138 10.1016/j.exphem.2017.11.002 10.1038/s41586-018-0623-z 10.1056/NEJMoa1409405 10.1016/j.cell.2021.01.049 10.1016/j.canlet.2019.09.013 10.1182/blood.2022016835 10.1038/nri2726 10.1101/gad.268409.115 10.1016/j.stem.2008.01.015 10.1016/j.celrep.2017.04.074 10.1016/j.stem.2017.06.013 10.1016/j.ccr.2011.06.001 10.1016/j.celrep.2019.07.094 10.1016/j.celrep.2017.03.018 10.1093/eurheartj/ehy128 10.1016/S1074-7613(03)00299-1 10.1093/nar/gky1020 10.1038/s41556-018-0121-4 10.1056/NEJMoa1701719 10.1182/bloodadvances.2018023986 10.1038/s41421-018-0072-8 10.1186/2050-6511-14-40 10.1038/nprot.2016.187 10.1016/j.cell.2017.07.032 10.1126/science.1256271 10.1016/j.cell.2019.05.031 10.1016/j.jclinepi.2014.03.012 10.3390/ijms20112710 10.1128/MCB.01525-12 10.1182/bloodadvances.2021004609 10.1038/s41598-017-03784-9 10.1158/2159-8290.CD-21-1146 10.1016/j.immuni.2017.09.008 10.1056/NEJMoa1408617 10.1016/S0301-472X(01)00670-1 10.4049/jimmunol.159.7.3364 10.1038/s41375-018-0112-2 10.1016/j.stem.2018.10.013 10.1038/s41586-020-2819-2 10.1016/j.cmet.2013.06.002 10.1182/blood-2017-04-777029 10.1038/s41556-019-0439-6 10.1038/ncb3346 10.1016/j.ccell.2022.07.002 10.1093/nar/gkv007 10.1182/blood-2019-128026 10.1158/0008-5472.CAN-14-0739 10.1093/bioinformatics/btr167 10.1038/nprot.2012.101 10.1016/j.ccr.2006.02.017 10.1182/blood-2015-11-679985 10.1016/j.cell.2008.01.020 10.1038/nmeth.2639 10.1038/s41588-020-0595-4 10.1126/sciadv.abj7293 10.2202/1544-6115.1027 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 2023. The Author(s). The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 ADTOC UNPAY DOA |
DOI | 10.1038/s41467-023-43697-y |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central (subscription) Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 17 |
ExternalDocumentID | oai_doaj_org_article_46073c65efef47319cd7fee492ddc3b3 10.1038/s41467-023-43697-y 38062031 10_1038_s41467_023_43697_y |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: American Cancer Society, Knight Pilot project – fundername: NHLBI NIH HHS grantid: R01 HL155426 – fundername: NCI NIH HHS grantid: R01 CA229875 |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LGEZI LK8 LOTEE M1P M48 M7P M~E NADUK NAO NXXTH O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 4.4 ABAWZ ADTOC BAPOH CAG COF EJD UNPAY |
ID | FETCH-LOGICAL-c485t-b0de6c0f57d1b4415215ee9c4d8f80925384b1637e64cd18c27ed6d926dbbc23 |
IEDL.DBID | C6C |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:06:44 EDT 2025 Wed Aug 20 00:06:43 EDT 2025 Sun Aug 24 03:15:29 EDT 2025 Wed Aug 13 07:01:41 EDT 2025 Tue May 06 01:31:46 EDT 2025 Wed Oct 01 02:52:48 EDT 2025 Thu Apr 24 23:10:01 EDT 2025 Fri Feb 21 02:38:14 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2023. The Author(s). cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-b0de6c0f57d1b4415215ee9c4d8f80925384b1637e64cd18c27ed6d926dbbc23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4218-582X 0000-0002-8319-6162 0000-0001-7985-1921 0000-0003-1808-7012 |
OpenAccessLink | https://www.nature.com/articles/s41467-023-43697-y |
PMID | 38062031 |
PQID | 2899186620 |
PQPubID | 546298 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_46073c65efef47319cd7fee492ddc3b3 unpaywall_primary_10_1038_s41467_023_43697_y proquest_miscellaneous_2902945778 proquest_journals_2899186620 pubmed_primary_38062031 crossref_citationtrail_10_1038_s41467_023_43697_y crossref_primary_10_1038_s41467_023_43697_y springer_journals_10_1038_s41467_023_43697_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-07 |
PublicationDateYYYYMMDD | 2023-12-07 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2023 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Burns (CR43) 2022; 36 Ågerstam (CR54) 2016; 128 Wahlestedt (CR30) 2017; 21 Jung (CR23) 2013; 18 Jaiswal (CR17) 2017; 377 Buscarlet (CR2) 2017; 130 Knudsen (CR26) 2015; 29 Kumar (CR31) 2019; 3 Dakic, Wu, Nutt (CR39) 2007; 28 Tabas, Lichtman (CR53) 2017; 47 Yamazaki (CR33) 2015; 75 Caiado (CR46) 2023; 141 Meisel (CR8) 2018; 557 Wang (CR4) 2020; 5 Jaiswal (CR3) 2017; 377 Bick (CR16) 2020; 586 Ferreira (CR35) 2013; 33 Macaulay (CR67) 2016; 11 Cimmino (CR18) 2017; 170 Ito (CR51) 2019; 28 Trumpp, Essers, Wilson (CR21) 2010; 10 Krueger, Andrews (CR70) 2011; 27 Sano (CR15) 2018; 71 Genovese (CR1) 2014; 371 Tulstrup (CR34) 2021; 12 Carey (CR14) 2017; 18 CR47 Glaccum (CR42) 1997; 159 Takizawa (CR29) 2017; 21 Abegunde, Buckstein, Wells, Rauh (CR11) 2018; 59 Hosseini (CR13) 2018; 32 Izzo (CR32) 2020; 52 Min (CR28) 2008; 2 Ostrander (CR48) 2020; 14 Heyde (CR10) 2021; 184 Giladi (CR58) 2018; 20 Clark (CR66) 2017; 12 Glickman, Rao, Schultz (CR65) 2014; 67 Ye (CR20) 2003; 19 Hayden, Ghosh (CR50) 2008; 132 Buckley, Abbate (CR55) 2018; 39 Stuart (CR56) 2019; 177 Bottomly (CR62) 2022; 40 Zeng (CR9) 2019; 467 Lang, Raffi (CR49) 2019; 20 Tyner (CR61) 2018; 562 Kirschner (CR25) 2017; 19 Ariki (CR27) 2014; 9 Baccin (CR59) 2020; 22 Lara-Astiaso (CR71) 2014; 345 Cai (CR7) 2018; 23 Picelli (CR68) 2013; 10 Yeaton (CR44) 2022; 12 Lacorazza (CR38) 2006; 9 Sato (CR40) 2019; 134 Mallaney (CR24) 2019; 33 Jafri, Moore, Morrell, Ormiston (CR19) 2017; 7 Feng, Liu, Qin, Zhang, Liu (CR72) 2012; 7 CR69 Moran-Crusio (CR6) 2011; 20 Ritchie (CR63) 2015; 43 Deen (CR36) 2021; 5 Urien (CR45) 2013; 14 CR64 Ridker (CR12) 2017; 390 Pietras (CR22) 2016; 18 Cull, Snetsinger, Buckstein, Wells, Rauh (CR52) 2017; 55 Jaiswal (CR5) 2014; 371 Xiao (CR41) 2019; 5 Cao (CR60) 2019; 566 Chen, Zhang (CR37) 2001; 29 Choi (CR57) 2019; 47 S Jaiswal (43697_CR17) 2017; 377 J Choi (43697_CR57) 2019; 47 A Giladi (43697_CR58) 2018; 20 ME Ritchie (43697_CR63) 2015; 43 SJ Clark (43697_CR66) 2017; 12 IC Macaulay (43697_CR67) 2016; 11 R Lang (43697_CR49) 2019; 20 A Yeaton (43697_CR44) 2022; 12 A Carey (43697_CR14) 2017; 18 ME Glickman (43697_CR65) 2014; 67 H Zeng (43697_CR9) 2019; 467 MM Hosseini (43697_CR13) 2018; 32 A Heyde (43697_CR10) 2021; 184 J Cao (43697_CR60) 2019; 566 Y Wang (43697_CR4) 2020; 5 S Jaiswal (43697_CR5) 2014; 371 S Picelli (43697_CR68) 2013; 10 AH Cull (43697_CR52) 2017; 55 M Meisel (43697_CR8) 2018; 557 H Jung (43697_CR23) 2013; 18 S Sano (43697_CR15) 2018; 71 D Deen (43697_CR36) 2021; 5 SS Burns (43697_CR43) 2022; 36 K Kirschner (43697_CR25) 2017; 19 A Trumpp (43697_CR21) 2010; 10 M Wahlestedt (43697_CR30) 2017; 21 G Genovese (43697_CR1) 2014; 371 R Ariki (43697_CR27) 2014; 9 A Sato (43697_CR40) 2019; 134 S Jafri (43697_CR19) 2017; 7 D Lara-Astiaso (43697_CR71) 2014; 345 Z Cai (43697_CR7) 2018; 23 43697_CR47 EL Ostrander (43697_CR48) 2020; 14 K Moran-Crusio (43697_CR6) 2011; 20 IM Min (43697_CR28) 2008; 2 F Krueger (43697_CR70) 2011; 27 L Cimmino (43697_CR18) 2017; 170 K Ito (43697_CR51) 2019; 28 J Feng (43697_CR72) 2012; 7 LF Buckley (43697_CR55) 2018; 39 D Bottomly (43697_CR62) 2022; 40 AG Bick (43697_CR16) 2020; 586 H Takizawa (43697_CR29) 2017; 21 D Chen (43697_CR37) 2001; 29 MB Glaccum (43697_CR42) 1997; 159 PM Ridker (43697_CR12) 2017; 390 SO Abegunde (43697_CR11) 2018; 59 P Kumar (43697_CR31) 2019; 3 M Ye (43697_CR20) 2003; 19 T Stuart (43697_CR56) 2019; 177 JW Tyner (43697_CR61) 2018; 562 X Xiao (43697_CR41) 2019; 5 M Tulstrup (43697_CR34) 2021; 12 M Buscarlet (43697_CR2) 2017; 130 F Izzo (43697_CR32) 2020; 52 HD Lacorazza (43697_CR38) 2006; 9 F Caiado (43697_CR46) 2023; 141 A Dakic (43697_CR39) 2007; 28 J Yamazaki (43697_CR33) 2015; 75 MS Hayden (43697_CR50) 2008; 132 I Tabas (43697_CR53) 2017; 47 C Baccin (43697_CR59) 2020; 22 EM Pietras (43697_CR22) 2016; 18 43697_CR64 R Ferreira (43697_CR35) 2013; 33 H Ågerstam (43697_CR54) 2016; 128 S Jaiswal (43697_CR3) 2017; 377 C Mallaney (43697_CR24) 2019; 33 KJ Knudsen (43697_CR26) 2015; 29 S Urien (43697_CR45) 2013; 14 43697_CR69 |
References_xml | – volume: 5 start-page: e135204 year: 2020 ident: CR4 article-title: Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction publication-title: JCI Insight doi: 10.1172/jci.insight.135204 – volume: 557 start-page: 580 year: 2018 end-page: 584 ident: CR8 article-title: Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host publication-title: Nature doi: 10.1038/s41586-018-0125-z – volume: 71 start-page: 875 year: 2018 end-page: 886 ident: CR15 article-title: Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the il-1β/nlrp3 inflammasome publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2017.12.037 – volume: 14 start-page: 551 year: 2020 end-page: 560 ident: CR48 article-title: Divergent effects of dnmt3a and tet2 mutations on hematopoietic progenitor cell fitness publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2020.02.011 – volume: 12 year: 2021 ident: CR34 article-title: TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis publication-title: Nat. Commun. doi: 10.1038/s41467-021-26093-2 – volume: 21 start-page: 2251 year: 2017 end-page: 2263 ident: CR30 article-title: Critical modulation of hematopoietic lineage fate by hepatic leukemia factor publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.10.112 – volume: 55 start-page: 56 year: 2017 end-page: 70.e13 ident: CR52 article-title: Tet2 restrains inflammatory gene expression in macrophages publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2017.08.001 – volume: 390 start-page: 1833 year: 2017 end-page: 1842 ident: CR12 article-title: Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(17)32247-X – volume: 33 start-page: 2506 year: 2019 end-page: 2521 ident: CR24 article-title: Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis publication-title: Leukemia doi: 10.1038/s41375-019-0462-4 – volume: 28 start-page: 108 year: 2007 end-page: 114 ident: CR39 article-title: Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? publication-title: Trends Immunol. doi: 10.1016/j.it.2007.01.006 – volume: 9 start-page: e87646 year: 2014 end-page: e87646 ident: CR27 article-title: Homeodomain transcription factor Meis1 is a critical regulator of adult bone marrow hematopoiesis publication-title: PloS one doi: 10.1371/journal.pone.0087646 – volume: 566 start-page: 496 year: 2019 end-page: 502 ident: CR60 article-title: The single-cell transcriptional landscape of mammalian organogenesis publication-title: Nature doi: 10.1038/s41586-019-0969-x – volume: 36 start-page: 2531 year: 2022 end-page: 2534 ident: CR43 article-title: Il-1r1 drives leukemogenesis induced by Tet2 loss publication-title: Leukemia doi: 10.1038/s41375-022-01665-3 – volume: 11 start-page: 2081 year: 2016 end-page: 2103 ident: CR67 article-title: Separation and parallel sequencing of the genomes and transcriptomes of single cells using G&T-seq publication-title: Nat. Protoc. doi: 10.1038/nprot.2016.138 – volume: 59 start-page: 60 year: 2018 end-page: 65 ident: CR11 article-title: An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2017.11.002 – volume: 562 start-page: 526 year: 2018 end-page: 531 ident: CR61 article-title: Functional genomic landscape of acute myeloid leukaemia publication-title: Nature doi: 10.1038/s41586-018-0623-z – volume: 371 start-page: 2477 year: 2014 end-page: 2487 ident: CR1 article-title: Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence publication-title: N. Engl. J. Med doi: 10.1056/NEJMoa1409405 – volume: 184 start-page: 1348 year: 2021 end-page: 1361.e1322 ident: CR10 article-title: Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis publication-title: Cell doi: 10.1016/j.cell.2021.01.049 – volume: 467 start-page: 1 year: 2019 end-page: 8 ident: CR9 article-title: Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.09.013 – volume: 141 start-page: 886 year: 2023 end-page: 903 ident: CR46 article-title: Aging drives Tet2+/− clonal hematopoiesis via IL-1 signaling publication-title: Blood doi: 10.1182/blood.2022016835 – volume: 10 start-page: 201 year: 2010 end-page: 209 ident: CR21 article-title: Awakening dormant haematopoietic stem cells publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2726 – volume: 29 start-page: 1915 year: 2015 end-page: 1929 ident: CR26 article-title: ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation publication-title: Genes Dev. doi: 10.1101/gad.268409.115 – volume: 2 start-page: 380 year: 2008 end-page: 391 ident: CR28 article-title: The transcription factor egr1 controls both the proliferation and localization of hematopoietic stem cells publication-title: Cell Stem Cell doi: 10.1016/j.stem.2008.01.015 – volume: 19 start-page: 1503 year: 2017 end-page: 1511 ident: CR25 article-title: Proliferation drives aging-related functional decline in a subpopulation of the hematopoietic stem cell compartment publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.04.074 – volume: 21 start-page: 225 year: 2017 end-page: 240.e225 ident: CR29 article-title: Pathogen-Induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness publication-title: Cell Stem Cell doi: 10.1016/j.stem.2017.06.013 – volume: 20 start-page: 11 year: 2011 end-page: 24 ident: CR6 article-title: Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation publication-title: Cancer Cell doi: 10.1016/j.ccr.2011.06.001 – volume: 28 start-page: 2480 year: 2019 end-page: 2490.e2484 ident: CR51 article-title: Non-catalytic roles of tet2 are essential to regulate hematopoietic stem and progenitor cell homeostasis publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.07.094 – volume: 18 start-page: 3204 year: 2017 end-page: 3218 ident: CR14 article-title: Identification of Interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.03.018 – volume: 39 start-page: 2063 year: 2018 end-page: 2069 ident: CR55 article-title: Interleukin-1 blockade in cardiovascular diseases: a clinical update publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehy128 – volume: 19 start-page: 689 year: 2003 end-page: 699 ident: CR20 article-title: Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential publication-title: Immunity doi: 10.1016/S1074-7613(03)00299-1 – ident: CR64 – volume: 47 start-page: D780 year: 2019 end-page: D785 ident: CR57 article-title: Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans publication-title: Nucleic Acids Res doi: 10.1093/nar/gky1020 – volume: 20 start-page: 836 year: 2018 end-page: 846 ident: CR58 article-title: Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0121-4 – volume: 377 start-page: 111 year: 2017 end-page: 121 ident: CR17 article-title: Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1701719 – volume: 3 start-page: 681 year: 2019 end-page: 691 ident: CR31 article-title: HMGA2 promotes long-term engraftment and myeloerythroid differentiation of human hematopoietic stem and progenitor cells publication-title: Blood Adv. doi: 10.1182/bloodadvances.2018023986 – volume: 5 start-page: 2 year: 2019 ident: CR41 article-title: Targeting JNK pathway promotes human hematopoietic stem cell expansion publication-title: Cell Discov. doi: 10.1038/s41421-018-0072-8 – volume: 14 start-page: 40 year: 2013 end-page: 40 ident: CR45 article-title: Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes publication-title: BMC Pharm. Toxicol. doi: 10.1186/2050-6511-14-40 – volume: 12 start-page: 534 year: 2017 end-page: 547 ident: CR66 article-title: Genome-wide base-resolution mapping of DNA methylation in single cells using single-cell bisulfite sequencing (scBS-seq) publication-title: Nat. Protoc. doi: 10.1038/nprot.2016.187 – volume: 170 start-page: 1079 year: 2017 end-page: 1095.e1020 ident: CR18 article-title: Restoration of TET2 function blocks aberrant self-renewal and leukemia progression publication-title: Cell doi: 10.1016/j.cell.2017.07.032 – ident: CR47 – volume: 345 start-page: 943 year: 2014 end-page: 949 ident: CR71 article-title: Chromatin state dynamics during blood formation publication-title: Science doi: 10.1126/science.1256271 – volume: 177 start-page: 1888 year: 2019 end-page: 1902.e1821 ident: CR56 article-title: Comprehensive integration of single-cell data publication-title: Cell doi: 10.1016/j.cell.2019.05.031 – volume: 67 start-page: 850 year: 2014 end-page: 857 ident: CR65 article-title: False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies publication-title: J. Clin. Epidemiol. doi: 10.1016/j.jclinepi.2014.03.012 – volume: 20 start-page: 2710 year: 2019 ident: CR49 article-title: Dual-specificity phosphatases in immunity and infection: an update publication-title: Int J. Mol. Sci. doi: 10.3390/ijms20112710 – volume: 33 start-page: 1254 year: 2013 end-page: 1266 ident: CR35 article-title: Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.01525-12 – volume: 5 start-page: 3002 year: 2021 end-page: 3015 ident: CR36 article-title: Identification of the transcription factor MAZ as a regulator of erythropoiesis publication-title: Blood Adv. doi: 10.1182/bloodadvances.2021004609 – volume: 7 year: 2017 ident: CR19 article-title: A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model publication-title: Sci. Rep. doi: 10.1038/s41598-017-03784-9 – volume: 12 start-page: 2392 year: 2022 end-page: 2413 ident: CR44 article-title: The impact of inflammation-induced tumor plasticity during myeloid transformation publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-21-1146 – volume: 47 start-page: 621 year: 2017 end-page: 634 ident: CR53 article-title: Monocyte-macrophages and T cells in atherosclerosis publication-title: Immunity doi: 10.1016/j.immuni.2017.09.008 – volume: 371 start-page: 2488 year: 2014 end-page: 2498 ident: CR5 article-title: Age-related clonal hematopoiesis associated with adverse outcomes publication-title: N. Engl. J. Med doi: 10.1056/NEJMoa1408617 – volume: 29 start-page: 971 year: 2001 end-page: 980 ident: CR37 article-title: Enforced expression of the GATA-3 transcription factor affects cell fate decisions in hematopoiesis publication-title: Exp. Hematol. doi: 10.1016/S0301-472X(01)00670-1 – volume: 159 start-page: 3364 year: 1997 ident: CR42 article-title: Phenotypic and functional characterization of mice that lack the type I receptor for IL-1 publication-title: J. Immunol. doi: 10.4049/jimmunol.159.7.3364 – volume: 32 start-page: 2374 year: 2018 end-page: 2387 ident: CR13 article-title: Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes publication-title: Leukemia doi: 10.1038/s41375-018-0112-2 – ident: CR69 – volume: 23 start-page: 833 year: 2018 end-page: 849.e835 ident: CR7 article-title: Inhibition of inflammatory signaling in tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis publication-title: Cell Stem Cell doi: 10.1016/j.stem.2018.10.013 – volume: 586 start-page: 763 year: 2020 end-page: 768 ident: CR16 article-title: Inherited causes of clonal haematopoiesis in 97,691 whole genomes publication-title: Nature doi: 10.1038/s41586-020-2819-2 – volume: 18 start-page: 75 year: 2013 end-page: 85 ident: CR23 article-title: TXNIP maintains the hematopoietic cell pool by switching the function of p53 under oxidative stress publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.06.002 – volume: 130 start-page: 753 year: 2017 end-page: 762 ident: CR2 article-title: DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions publication-title: Blood doi: 10.1182/blood-2017-04-777029 – volume: 22 start-page: 38 year: 2020 end-page: 48 ident: CR59 article-title: Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization publication-title: Nat. Cell Biol. doi: 10.1038/s41556-019-0439-6 – volume: 18 start-page: 607 year: 2016 end-page: 618 ident: CR22 article-title: Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal publication-title: Nat. Cell Biol. doi: 10.1038/ncb3346 – volume: 40 start-page: 850 year: 2022 end-page: 864 ident: CR62 article-title: Integrative analysis of drug response and clinical outcome in acute myeloid leukemia publication-title: Cancer Cell doi: 10.1016/j.ccell.2022.07.002 – volume: 43 start-page: e47 year: 2015 end-page: e47 ident: CR63 article-title: limma powers differential expression analyses for RNA-sequencing and microarray studies publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv007 – volume: 134 start-page: 3713 year: 2019 end-page: 3713 ident: CR40 article-title: C/EBPβ isoforms regulate proliferation and differentiation of regenerating hematopoietic stem/progenitor cells publication-title: Blood doi: 10.1182/blood-2019-128026 – volume: 377 start-page: 111 year: 2017 end-page: 121 ident: CR3 article-title: Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease publication-title: N. Engl. J. Med doi: 10.1056/NEJMoa1701719 – volume: 75 start-page: 2833 year: 2015 end-page: 2843 ident: CR33 article-title: TET2 mutations affect non-cpg island dna methylation at enhancers and transcription factor-binding sites in chronic myelomonocytic leukemia publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-0739 – volume: 27 start-page: 1571 year: 2011 end-page: 1572 ident: CR70 article-title: Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr167 – volume: 7 start-page: 1728 year: 2012 end-page: 1740 ident: CR72 article-title: Identifying ChIP-seq enrichment using MACS publication-title: Nat. Protoc. doi: 10.1038/nprot.2012.101 – volume: 9 start-page: 175 year: 2006 end-page: 187 ident: CR38 article-title: The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.02.017 – volume: 128 start-page: 2683 year: 2016 end-page: 2693 ident: CR54 article-title: IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models publication-title: Blood doi: 10.1182/blood-2015-11-679985 – volume: 132 start-page: 344 year: 2008 end-page: 362 ident: CR50 article-title: Shared principles in NF-κB signaling publication-title: Cell doi: 10.1016/j.cell.2008.01.020 – volume: 10 start-page: 1096 year: 2013 end-page: 1098 ident: CR68 article-title: Smart-seq2 for sensitive full-length transcriptome profiling in single cells publication-title: Nat. Methods doi: 10.1038/nmeth.2639 – volume: 52 start-page: 378 year: 2020 end-page: 387 ident: CR32 article-title: DNA methylation disruption reshapes the hematopoietic differentiation landscape publication-title: Nat. Genet. doi: 10.1038/s41588-020-0595-4 – volume: 5 start-page: 2 year: 2019 ident: 43697_CR41 publication-title: Cell Discov. doi: 10.1038/s41421-018-0072-8 – volume: 19 start-page: 1503 year: 2017 ident: 43697_CR25 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.04.074 – volume: 29 start-page: 971 year: 2001 ident: 43697_CR37 publication-title: Exp. Hematol. doi: 10.1016/S0301-472X(01)00670-1 – volume: 18 start-page: 607 year: 2016 ident: 43697_CR22 publication-title: Nat. Cell Biol. doi: 10.1038/ncb3346 – volume: 345 start-page: 943 year: 2014 ident: 43697_CR71 publication-title: Science doi: 10.1126/science.1256271 – volume: 28 start-page: 108 year: 2007 ident: 43697_CR39 publication-title: Trends Immunol. doi: 10.1016/j.it.2007.01.006 – volume: 132 start-page: 344 year: 2008 ident: 43697_CR50 publication-title: Cell doi: 10.1016/j.cell.2008.01.020 – volume: 7 start-page: 1728 year: 2012 ident: 43697_CR72 publication-title: Nat. Protoc. doi: 10.1038/nprot.2012.101 – volume: 11 start-page: 2081 year: 2016 ident: 43697_CR67 publication-title: Nat. Protoc. doi: 10.1038/nprot.2016.138 – ident: 43697_CR69 – volume: 12 start-page: 534 year: 2017 ident: 43697_CR66 publication-title: Nat. Protoc. doi: 10.1038/nprot.2016.187 – volume: 29 start-page: 1915 year: 2015 ident: 43697_CR26 publication-title: Genes Dev. doi: 10.1101/gad.268409.115 – volume: 9 start-page: e87646 year: 2014 ident: 43697_CR27 publication-title: PloS one doi: 10.1371/journal.pone.0087646 – volume: 5 start-page: e135204 year: 2020 ident: 43697_CR4 publication-title: JCI Insight doi: 10.1172/jci.insight.135204 – volume: 566 start-page: 496 year: 2019 ident: 43697_CR60 publication-title: Nature doi: 10.1038/s41586-019-0969-x – volume: 33 start-page: 2506 year: 2019 ident: 43697_CR24 publication-title: Leukemia doi: 10.1038/s41375-019-0462-4 – ident: 43697_CR47 doi: 10.1126/sciadv.abj7293 – volume: 562 start-page: 526 year: 2018 ident: 43697_CR61 publication-title: Nature doi: 10.1038/s41586-018-0623-z – volume: 377 start-page: 111 year: 2017 ident: 43697_CR3 publication-title: N. Engl. J. Med doi: 10.1056/NEJMoa1701719 – volume: 14 start-page: 40 year: 2013 ident: 43697_CR45 publication-title: BMC Pharm. Toxicol. doi: 10.1186/2050-6511-14-40 – volume: 40 start-page: 850 year: 2022 ident: 43697_CR62 publication-title: Cancer Cell doi: 10.1016/j.ccell.2022.07.002 – volume: 27 start-page: 1571 year: 2011 ident: 43697_CR70 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr167 – volume: 128 start-page: 2683 year: 2016 ident: 43697_CR54 publication-title: Blood doi: 10.1182/blood-2015-11-679985 – volume: 10 start-page: 1096 year: 2013 ident: 43697_CR68 publication-title: Nat. Methods doi: 10.1038/nmeth.2639 – volume: 14 start-page: 551 year: 2020 ident: 43697_CR48 publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2020.02.011 – volume: 18 start-page: 3204 year: 2017 ident: 43697_CR14 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.03.018 – volume: 20 start-page: 11 year: 2011 ident: 43697_CR6 publication-title: Cancer Cell doi: 10.1016/j.ccr.2011.06.001 – volume: 52 start-page: 378 year: 2020 ident: 43697_CR32 publication-title: Nat. Genet. doi: 10.1038/s41588-020-0595-4 – volume: 39 start-page: 2063 year: 2018 ident: 43697_CR55 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehy128 – volume: 177 start-page: 1888 year: 2019 ident: 43697_CR56 publication-title: Cell doi: 10.1016/j.cell.2019.05.031 – ident: 43697_CR64 doi: 10.2202/1544-6115.1027 – volume: 47 start-page: D780 year: 2019 ident: 43697_CR57 publication-title: Nucleic Acids Res doi: 10.1093/nar/gky1020 – volume: 371 start-page: 2488 year: 2014 ident: 43697_CR5 publication-title: N. Engl. J. Med doi: 10.1056/NEJMoa1408617 – volume: 32 start-page: 2374 year: 2018 ident: 43697_CR13 publication-title: Leukemia doi: 10.1038/s41375-018-0112-2 – volume: 75 start-page: 2833 year: 2015 ident: 43697_CR33 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-0739 – volume: 184 start-page: 1348 year: 2021 ident: 43697_CR10 publication-title: Cell doi: 10.1016/j.cell.2021.01.049 – volume: 7 year: 2017 ident: 43697_CR19 publication-title: Sci. Rep. doi: 10.1038/s41598-017-03784-9 – volume: 10 start-page: 201 year: 2010 ident: 43697_CR21 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2726 – volume: 47 start-page: 621 year: 2017 ident: 43697_CR53 publication-title: Immunity doi: 10.1016/j.immuni.2017.09.008 – volume: 3 start-page: 681 year: 2019 ident: 43697_CR31 publication-title: Blood Adv. doi: 10.1182/bloodadvances.2018023986 – volume: 28 start-page: 2480 year: 2019 ident: 43697_CR51 publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.07.094 – volume: 467 start-page: 1 year: 2019 ident: 43697_CR9 publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.09.013 – volume: 9 start-page: 175 year: 2006 ident: 43697_CR38 publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.02.017 – volume: 21 start-page: 225 year: 2017 ident: 43697_CR29 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2017.06.013 – volume: 21 start-page: 2251 year: 2017 ident: 43697_CR30 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.10.112 – volume: 71 start-page: 875 year: 2018 ident: 43697_CR15 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2017.12.037 – volume: 22 start-page: 38 year: 2020 ident: 43697_CR59 publication-title: Nat. Cell Biol. doi: 10.1038/s41556-019-0439-6 – volume: 33 start-page: 1254 year: 2013 ident: 43697_CR35 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.01525-12 – volume: 59 start-page: 60 year: 2018 ident: 43697_CR11 publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2017.11.002 – volume: 586 start-page: 763 year: 2020 ident: 43697_CR16 publication-title: Nature doi: 10.1038/s41586-020-2819-2 – volume: 377 start-page: 111 year: 2017 ident: 43697_CR17 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1701719 – volume: 12 start-page: 2392 year: 2022 ident: 43697_CR44 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-21-1146 – volume: 134 start-page: 3713 year: 2019 ident: 43697_CR40 publication-title: Blood doi: 10.1182/blood-2019-128026 – volume: 55 start-page: 56 year: 2017 ident: 43697_CR52 publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2017.08.001 – volume: 23 start-page: 833 year: 2018 ident: 43697_CR7 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2018.10.013 – volume: 390 start-page: 1833 year: 2017 ident: 43697_CR12 publication-title: Lancet doi: 10.1016/S0140-6736(17)32247-X – volume: 557 start-page: 580 year: 2018 ident: 43697_CR8 publication-title: Nature doi: 10.1038/s41586-018-0125-z – volume: 20 start-page: 836 year: 2018 ident: 43697_CR58 publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0121-4 – volume: 19 start-page: 689 year: 2003 ident: 43697_CR20 publication-title: Immunity doi: 10.1016/S1074-7613(03)00299-1 – volume: 43 start-page: e47 year: 2015 ident: 43697_CR63 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv007 – volume: 371 start-page: 2477 year: 2014 ident: 43697_CR1 publication-title: N. Engl. J. Med doi: 10.1056/NEJMoa1409405 – volume: 2 start-page: 380 year: 2008 ident: 43697_CR28 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2008.01.015 – volume: 36 start-page: 2531 year: 2022 ident: 43697_CR43 publication-title: Leukemia doi: 10.1038/s41375-022-01665-3 – volume: 141 start-page: 886 year: 2023 ident: 43697_CR46 publication-title: Blood doi: 10.1182/blood.2022016835 – volume: 130 start-page: 753 year: 2017 ident: 43697_CR2 publication-title: Blood doi: 10.1182/blood-2017-04-777029 – volume: 170 start-page: 1079 year: 2017 ident: 43697_CR18 publication-title: Cell doi: 10.1016/j.cell.2017.07.032 – volume: 18 start-page: 75 year: 2013 ident: 43697_CR23 publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.06.002 – volume: 67 start-page: 850 year: 2014 ident: 43697_CR65 publication-title: J. Clin. Epidemiol. doi: 10.1016/j.jclinepi.2014.03.012 – volume: 5 start-page: 3002 year: 2021 ident: 43697_CR36 publication-title: Blood Adv. doi: 10.1182/bloodadvances.2021004609 – volume: 20 start-page: 2710 year: 2019 ident: 43697_CR49 publication-title: Int J. Mol. Sci. doi: 10.3390/ijms20112710 – volume: 159 start-page: 3364 year: 1997 ident: 43697_CR42 publication-title: J. Immunol. doi: 10.4049/jimmunol.159.7.3364 – volume: 12 year: 2021 ident: 43697_CR34 publication-title: Nat. Commun. doi: 10.1038/s41467-021-26093-2 |
SSID | ssj0000391844 |
Score | 2.541594 |
Snippet | Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs. When... Abstract Clonal hematopoiesis (CH) is defined as a single hematopoietic stem/progenitor cell (HSPC) gaining selective advantage over a broader range of HSPCs.... |
SourceID | doaj unpaywall proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 8102 |
SubjectTerms | 38/89 38/91 59 631/250/127/1213 631/250/232 631/532/2441 631/67/1990/283 64 64/110 64/60 96 96/100 96/21 96/95 Animal models Animals Binding sites Cardiovascular disease Cardiovascular diseases Cell self-renewal Cells (biology) Clonal deletion Clonal Hematopoiesis Demethylation Differentiation Dioxygenases - metabolism DNA methylation DNA-Binding Proteins - metabolism Enhancers Epigenesis, Genetic Epigenetics Genes Hematopoiesis Hematopoiesis - genetics Hematopoietic stem cells Hematopoietic Stem Cells - metabolism Hemopoiesis Humanities and Social Sciences Humans Inflammation Leukemia Macrophages Malignancy Methylation Mice Monocytes multidisciplinary Mutation Progenitor cells Regulatory sequences Science Science (multidisciplinary) Transcription factors Transcription Factors - genetics Transcription Factors - metabolism |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NihQxEA6yIOpB_N_WVSJ4c8P25KeTHHXZZRX1NMLeQv4aBtruYXsGmYfwZXwQn8lUuqdtQVYPXrsroZL6kqqQ1FcIvRLcxuC1JLWkNeHBM6JCGYlW1MlaC6csJCd__FRdfObvL8XlrNQXvAkb6IGHiTvhVQKhr0SsY81lAowPso6RaxpSxy7zfCY3NjtM5T2Y6XR04WOWTMnUSc_znpBcFOGsSsrtfvNEmbD_T1Hm7Ib0Drq1bdd299U2zcwJnd9Dd8foEb8ZtL6PbsT2Abo51JPcPUTfThsIrHEmYu3WXToFr3qc01ViwMuzJcVNUoV0NQF_BjbBqxQ3h9jjdx8WP76TnEgCwnENNJ2Q4YiB9zI_4vqS9MOrdtY9_AYmaGzbgEEqwg5xheE6oH-Eludny9MLMtZbIJ4rsSGuDLHyZS1kWDiePbuIUXseVK1KTdPeyF2K32SsuA8L5amMoQqaVsE5T9ljdNB2bTxEuLJMBCczdQy3KQbjMlLHhbOCM2tFgRb7qTd-5CKHkhiNyXfiTJnBXCaZy2RzmV2BXk9t1gMTx7XSb8GikySwaOcPCVtmxJb5G7YKdLTHgxmXdm_ghAosgbQs0Mvpd1qUMLW2jd02yeiSai6kVAV6MuBo0oSpMrVliwId74H1q_PrBnQ8ge8fxv_0f4z_GbpNYcHA6x15hA42V9v4PMVgG_ciL7efukYubQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Li9RAEG50RVwP4tvoKi14c5tN-pHunESXHVdRTyPsLfQrMhCT7GQGmR_hn_GH-Jvs6mSyI8jgNV0Jla5nP-orhF4Jrr2zhSSVpBXhzjKiXOpJoaiRVSGM0lCc_PlLfv6Vf7wQF-OGWz9eq9z6xOioXWthj_wEFgYAzkbTN90lga5RcLo6ttC4jm5kNGgSVIrP3k97LIB-rjgfa2VSpk56Hj1DCFSEszywuPkrHkXY_n_lmjvnpLfRrXXT6c0PXdc7oWh2F90Zc0j8dhD6PXTNN_fRzaGr5OYB-nlaQ3qNIxxr27VhLbzocSxa8Q7Pz-YU14EV0lYEohpIBi9C9ux8jz98yn7_IrGcBIh9B2CdUOeIAf0yXuX6HvjDi2bn8zAMeNBYNw4DlQc_scRwKNA_RPPZ2fz0nIxdF4jlSqyISZ3PbVoJ6TLDY3wX3heWO1WptKDBQ3ITsjjpc25dpiyV3uWuoLkzxlL2CB00beOfIJxrJpyREUCG65CJcemp4cJowZnWIkHZdupLOyKSQ2OMuown40yVg7jKIK4yiqvcJOj19E434HHspX4HEp0oAUs7PmiX38rRNEueBzdnc-ErX3EZXJJ1svKeF9QF1TUsQUdbfShHA-_LK3VM0MtpOJgmTK1ufLsONEVKCy6kVAl6POjRxAlTaXiXZQk63irW1cf3_dDxpHz_8f9P97P-DB1SMAW4nSOP0MFqufbPQ461Mi-iIf0BlbAlCA priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LbtQwFLVKEaIsEG8CBRmJHTVNHDt2FghB1aogymoqdRf5FTRSSKaTGUE-gp_hQ_gmfJ0HgzSqYBtfO7bv07LvuQi95Ew5a3JBSkFLwqxJibSxI7mkWpQ511JBcvLZ5-z0nH284Bc7aCx3NGxgu_VoB_WkzpfV6--X3Vuv8G_6lHF52LKg7t77EJZm_r_dNXTdeyYKUn42hPvBMqe5P9CwIXdme9e__FOA8d8We27cm95CN9f1QnXfVFVtuKaTO-j2EFPid70Q3EU7rr6HbvRVJrv76MdRBeE2DvCszaLxZ-N5i0MSi7N4djyjuPJTIU1JwMsBp_DcR9PWtfjDp-TXTxLSS4DYLQC8E_IeMaBhhqddX_388LzeGB6aAR8aq9pioHJgN5YYLgnaB2h2cjw7OiVDFQZimOQromPrMhOXXNhEs-DvuXO5YVaWMs6pt5hM-6hOuIwZm0hDhbOZzWlmtTY0fYh266Z2jxHOVMqtFgFQhikfmTHhqGZcK85SpXiEknHrCzMglEOhjKoIN-WpLHp2FZ5dRWBX0UXo1dRn0eNzXEn9Hjg6UQK2dvjQLL8Ug6oWLPNmz2Tcla5kwpsoY0XpHMup9aKs0wjtj_JQjPJawLkVsANpHKEXU7NXVdhaVbtm7WnymOaMCyEj9KiXo2kmqYx93zSJ0MEoWH8Gv2pBB5Pw_cP6n_zf6E_RHgXVgNc7Yh_trpZr98zHYCv9PCjWb7KOLP8 priority: 102 providerName: Scholars Portal – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbKVohy4F0IFGQkbtRL4neOpWpVEFQctqKcovgRtGJJVvsQWv4Df4Yfwm_C4yTLgqqKXuOx5RmPZyaamc8IvRC89M7milSKVoQ7y4h2qSe5pkZVuTC6hObk96fy5Iy_PRfnW0j2vTCxaD9CWkYz3VeHvZrzeKWDhyGcybD2ajh11TW0LSGxNEDbZ6cfDj7BS3Ipz0jwyqzrkEmZvmDyX14ogvVfFGFuZEdvohvLelquvpWTyYYDOr6NPvZbb-tOvgyXCzO03_9Bdbw6b3fQrS4mxQct5V205et76Hr7SuXqPvpxOIFwHUd412bahH_r8RzHJhjv8OhoRPEkMEmaioCXhJPG4xCNOz_Hb95lv36S2J4CxH4K4J_QN4kBTTOWhn0NnONxvbE8DAO-NC5rh4HKg92ZYUgyzB-g0fHR6PCEdK84EMu1WBCTOi9tWgnlMsNjvCC8zy13utJpToPF5SZEhcpLbl2mLVXeSZdT6YyxlO2iQd3U_hHCsmTCGRUBaXgZIjuuPDVcmFJwVpYiQVl_qIXtEM7hoY1JETPtTBetpIsg6SJKulgl6OV6zrTF97iU-jXoypoSsLnjh2b2uejOs-AymE0rha98xVUwcdapynueUxeugmEJ2us1regMxryA_17AHqRpgp6vh8NVB9GWtW-WgSZPac6FUjpBD1sNXe-E6TTMZVmC9nuV_bP4ZQztr9X6P_h_fDXyJ2iHglZD9Y_aQ4PFbOmfhhhuYZ51F_Y36BdDFQ priority: 102 providerName: Unpaywall |
Title | Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells |
URI | https://link.springer.com/article/10.1038/s41467-023-43697-y https://www.ncbi.nlm.nih.gov/pubmed/38062031 https://www.proquest.com/docview/2899186620 https://www.proquest.com/docview/2902945778 https://www.nature.com/articles/s41467-023-43697-y.pdf https://doaj.org/article/46073c65efef47319cd7fee492ddc3b3 |
UnpaywallVersion | publishedVersion |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: KQ8 dateStart: 20150101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Inspec with Full Text customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: ADMLS dateStart: 20121101 isFulltext: true titleUrlDefault: https://www.ebsco.com/products/research-databases/inspec-full-text providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: RPM dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAQT databaseName: Springer Nature - nature.com Journals - Fully Open Access customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: NAO dateStart: 20101201 isFulltext: true titleUrlDefault: https://www.nature.com/siteindex/index.html providerName: Nature Publishing – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 7X7 dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: BENPR dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Technology Collection customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 8FG dateStart: 20100401 isFulltext: true titleUrlDefault: https://search.proquest.com/technologycollection1 providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2041-1723 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M48 dateStart: 20101001 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: AAJSJ dateStart: 20101201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: C6C dateStart: 20101201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bjtMwELX2IgQ8IG4LgaUyEm-sReJL7Dx2q5alYqsVdKXyFNmxgyqVpOpFqB_Bz_AhfBMeNw1FWq3gxZHiseV4ZjzjeOYYoTeCa2eLTJJS0pJwWzCibOxIpqiRZSaM0pCcfDlKL675cCImB4jucmFC0H6AtAzL9C467N2SB5X2FoZwlvq-N4foWEmWQBhfL-21_1UA8Vxx3uTHxEzd0PQvGxSg-m_yL_fORu-ju-tqrjff9Wy2Z34GD9GDxm_E3e1IH6EDVz1Gd7Y3SW6eoB-9GbjUOECw1vPa73-nSxwSVZzF4_6Y4pkfCqlLApYMuIGn3mO2bok_fEx-_SQhhQSI3RwAOiG3EQPiZQjf-ubHh6fVXvdQDRjQWFcWA5WDtWGB4SBg-RSNB_1x74I0Ny2QgiuxIia2Li3iUkibGB5sunAuK7hVpYoz6ldFbrznJl3KC5uogkpnU5vR1BpTUHaCjqq6cs8RTjUT1sgAGsO19764dNRwYbTgTGsRoWQ39XnRoJDDZRizPJyGM5Vv2ZV7duWBXfkmQm_bNvMtBset1OfA0ZYS8LPDi3rxNW_kKeepX9qKVLjSldxLUVZYWTrHM2q9uBoWodOdPOSNUi9z2JsCPiCNI_S6rfbqCFOrK1evPU0W04wLKVWEnm3lqB0JU7Fvy5IIne0E60_nt33QWSt8__D9L_6v95foHgXVgAgdeYqOVou1e-X9rJXpoEM5kb5Ug_cddNztDj8P_fO8P7r61AlK1wl_MHx5yZWvuR5ddb_8Bhe7K8s |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIlQ4IP4JFDASnKjVrGPHzgEhKK126banRerNin-CVlqSZbOrah-CR-HCg_BMeJyfLhJacek1nliOZ_zNOPZ8g9BrznJnTSZIIWhBmDUJkTZ2JJNUiyLjWuaQnHx2ng6_sM8X_GIH_exyYeBaZYeJAahtZeAf-SFsDICcjcbv598JVI2C09WuhEZjFqdufem3bPW70Sev3zeUnhxPjoakrSpADJN8SXRsXWriggs70Cz4L-5cZpiVhYwz6hGAaR-lCJcyYwfSUOFsajOaWq0N8Bx4xL_BkpgBVb-4EP0vHSBbl4y1qTlxIg9rFoDI-0XCktTPyPov9xeqBPwrtN04lr2N9lblPF9f5rPZhuc7uYvutCEr_tDY2D2048r76GZTxHL9AP04mkE0jwP7azWv_NZ7WuOQI-MsnhxPKJ75oZCqIOBEwRDw1Afr1tV4NB78_kVC9goIuzlwg0JaJQayzXBz7JsfH56WG91DM9BP47y0GKQcwNICwxlE_RBNrkMdj9BuWZXuCcJpnnCrReCrYbkP_JhwVDOuc86SPOcRGnRTr0xLgA51OGYqHMQnUjXqUl5dKqhLrSP0tn9n3tB_bJX-CBrtJYG6OzyoFl9ViwSKpR5VTcpd4QomPAIaKwrnWEatXyk6idB-Zw-qxZNaXVl_hF71zR4JYGrz0lUrL5PFNGNcCBmhx40d9SNJZOzfTQYROugM66rzbR900Bvff3z_0-1Df4n2hpOzsRqPzk-foVsUlgVcDBL7aHe5WLnnPrxb6hdhUWGkrnkR_wE3FGFW |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELZWi3gdEK-FwgJGghNrNXXs2DkgBLtbbdllxaFIvVnxI6hSSUrTatUfwZ_hxp_gN-FxHlskVHHZa-JEjmfmm3E88w1CrzjLnDWpILmgOWHWxETayJFUUi3ylGuZQXHyp_Pk5Av7OOGTHfSrrYWBtMoWEwNQ29LAP_I-bAyAnI1G_bxJi_h8NHw3_06ggxSctLbtNGoVOXXrC799q96OjrysX1M6PB4fnpCmwwAxTPIl0ZF1iYlyLuxAs-DLuHOpYVbmMkqpRwOmfcQiXMKMHUhDhbOJTWlitTbAeeDR_5qIWQzZZGIiut87QLwuGWvKdKJY9isWQMn7SMLixK_O-i9XGDoG_CvM3TiivY1urop5tr7IZrMNLzi8i-404St-X-vbPbTjivvoet3Qcv0A_TicQWSPAxNsOS_9Nnxa4VAv4yweH48pnvmpkDIn4FBBKfDUB-7WVXh0Nvj9k4RKFhjs5sATCiWWGIg3QxbZNz8_PC02Xg-3gYoaZ4XFMMoBRC0wnEdUD9H4KsSxh3aLsnCPEU6ymFstAncNy3wQyISjmnGdcRZnGe-hQbv0yjRk6NCTY6bCoXwsVS0u5cWlgrjUuofedM_MayqQraM_gES7kUDjHS6Ui6-qQQXFEo-wJuEudzkTHg2NFblzLKXWW42Oe2i_1QfVYEulLi2hh152tz0qwNJmhStXfkwa0ZRxIWQPPar1qJtJLCP_bDzooYNWsS5fvu2DDjrl-4_vf7J96i_QDW--6mx0fvoU3aJgFZAjJPbR7nKxcs98pLfUz4NNYaSu2Ib_ANX8ZZE |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbKVohy4F0IFGQkbtRL4neOpWpVEFQctqKcovgRtGJJVvsQWv4Df4Yfwm_C4yTLgqqKXuOx5RmPZyaamc8IvRC89M7milSKVoQ7y4h2qSe5pkZVuTC6hObk96fy5Iy_PRfnW0j2vTCxaD9CWkYz3VeHvZrzeKWDhyGcybD2ajh11TW0LSGxNEDbZ6cfDj7BS3Ipz0jwyqzrkEmZvmDyX14ogvVfFGFuZEdvohvLelquvpWTyYYDOr6NPvZbb-tOvgyXCzO03_9Bdbw6b3fQrS4mxQct5V205et76Hr7SuXqPvpxOIFwHUd412bahH_r8RzHJhjv8OhoRPEkMEmaioCXhJPG4xCNOz_Hb95lv36S2J4CxH4K4J_QN4kBTTOWhn0NnONxvbE8DAO-NC5rh4HKg92ZYUgyzB-g0fHR6PCEdK84EMu1WBCTOi9tWgnlMsNjvCC8zy13utJpToPF5SZEhcpLbl2mLVXeSZdT6YyxlO2iQd3U_hHCsmTCGRUBaXgZIjuuPDVcmFJwVpYiQVl_qIXtEM7hoY1JETPtTBetpIsg6SJKulgl6OV6zrTF97iU-jXoypoSsLnjh2b2uejOs-AymE0rha98xVUwcdapynueUxeugmEJ2us1regMxryA_17AHqRpgp6vh8NVB9GWtW-WgSZPac6FUjpBD1sNXe-E6TTMZVmC9nuV_bP4ZQztr9X6P_h_fDXyJ2iHglZD9Y_aQ4PFbOmfhhhuYZ51F_Y36BdDFQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clonal+hematopoiesis+related+TET2+loss-of-function+impedes+IL1%CE%B2-mediated+epigenetic+reprogramming+in+hematopoietic+stem+and+progenitor+cells&rft.jtitle=Nature+communications&rft.au=McClatchy%2C+J.&rft.au=Strogantsev%2C+R.&rft.au=Wolfe%2C+E.&rft.au=Lin%2C+H.+Y.&rft.date=2023-12-07&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-1723&rft.volume=14&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-023-43697-y&rft.externalDocID=10_1038_s41467_023_43697_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |